These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32432038)

  • 1. Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for
    Zhan W; Li H; Guo Y; Du G; Wu Y; Zhang D
    Front Oncol; 2020; 10():622. PubMed ID: 32432038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid functionalized biodegradable mesoporous silica nanocomposites for efficient photothermal and chemotherapy in breast cancer.
    Zhan W; Li H; Guo Y; Yang L; Pang L; Zhang C
    Nanotechnology; 2021 Apr; 32(16):165703. PubMed ID: 33429376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
    Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
    Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
    Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
    Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer.
    Li K; Zhan W; Chen Y; Jha RK; Chen X
    Front Pharmacol; 2019; 10():1436. PubMed ID: 31920642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
    Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
    Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
    Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery.
    Gui W; Zhang J; Chen X; Yu D; Ma Q
    Mikrochim Acta; 2017 Dec; 185(1):66. PubMed ID: 29594582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox stimuli-responsive hollow mesoporous silica nanocarriers for targeted drug delivery in cancer therapy.
    Tian Y; Guo R; Jiao Y; Sun Y; Shen S; Wang Y; Lu D; Jiang X; Yang W
    Nanoscale Horiz; 2016 Nov; 1(6):480-487. PubMed ID: 32260712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.